- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03391180
The Effect of ICON Treatment on WPL With Patients After Fixed Orthodontic Appliances
January 4, 2018 updated by: Omar Alkadhi, Riyadh Colleges of Dentistry and Pharmacy
The Effect of ICON Treatment on WPL With Patients After Fixed Orthodontic Appliances: A Randomized Controlled Trial
The aim of this study is to determine the effect of ICON on White spot lesions compared to CPP-ACPF plus.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
The participants were categorized to either group (group1) receiving ICON treatment method (Icon, DMG, Germany), or (group 2) who shall be receiving CPP-ACPF treatment method (Tooth Mousse plus).
Study Type
Interventional
Enrollment (Anticipated)
120
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Lougin K Brekeit, BDS
- Phone Number: 966556461314
- Email: lougin.bk@gmail.com
Study Locations
-
-
ArRiyadh
-
Riyadh, ArRiyadh, Saudi Arabia, 11681
- Riyadh Colleges of Dentistry and Pharmacy
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
10 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- permanent dentition, in good general health and without systemic diseases, who had received fixed orthodontic treatment.
Exclusion Criteria:
- Patients with primary dentition, enamel hypoplasia, dental fluorosis or tetracycline pigmentation and carious cavity were excluded.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: ICON Remineralization
Firstly, Conditioning of the WSL surface by 15% HCL gel (Icon-Etch, DNG) and subsequent application of the drying solution (Icon-Dry, DMG), Numbers of additional etching intervals have been determined by visual assessment after each of the etch/dry intervals to achieve individual, customized intensities of WSL surface conditioning.
|
A material used for the Remineralization of white spot lesions.
|
Active Comparator: CPP-ACPF
Participants in group 2 (CPP-ACPF) were treated with applying a pea sized amount of ACC-ACPF plus on a gloved finger of the examiner and rubbed the surface of the labial tooth for 4 minutes with advising the patient to avoid drinking and eating for the next 30 minutes of application.
|
Casein phosphopeptide-Amorphous calcium phosphate fluoride used for the remineralization of white spot lesions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Remineralization
Time Frame: 3 Months
|
Using DIAGNOdent Laser device.
|
3 Months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Omar H AlKadhi, Riyadh Colleges of Dentistry and Pharmacy
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
February 1, 2018
Primary Completion (Anticipated)
April 1, 2018
Study Completion (Anticipated)
July 1, 2018
Study Registration Dates
First Submitted
December 26, 2017
First Submitted That Met QC Criteria
January 4, 2018
First Posted (Actual)
January 5, 2018
Study Record Updates
Last Update Posted (Actual)
January 5, 2018
Last Update Submitted That Met QC Criteria
January 4, 2018
Last Verified
January 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- FGR/2018/45
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on White Spot Lesion
-
Al-Azhar UniversityEnrolling by invitation
-
Texas A&M UniversityCompletedWhite Spot LesionUnited States
-
Izmir Katip Celebi UniversityCompletedRemineralization | White Spot LesionTurkey
-
Universitat Internacional de CatalunyaCompleted
-
EgymedicalpediaCompleted
-
Hams Hamed AbdelrahmanCompletedWhite Spot LesionEgypt
-
Damascus UniversityCompletedWhite Spot LesionSyrian Arab Republic
-
Ivoclar Vivadent AGIuliu Hatieganu University of Medicine and PharmacyActive, not recruiting
-
Ondokuz Mayıs UniversityCompletedWhite Spot LesionTurkey
Clinical Trials on ICON Remineralization
-
Michigan State UniversityUnited States Department of Agriculture (USDA)Completed
-
Wuhan UniversityUnknown
-
Universidade Federal de Santa MariaUnknownTooth; Lesion, White Spot LesionsBrazil
-
Cynosure, Inc.RecruitingScars | Wrinkles | Skin Laxity | Pigmentation | Stretch MarksUnited States
-
Assiut UniversityNot yet recruitingValue of Non Invasive Hemodynamic Monitoring in Patients Admitted to Respiratory Intensive Care UnitNon-invasive Hemodynamic Monitoring
-
National Research Centre, EgyptCompletedWhite Spot Lesion of ToothEgypt
-
DePuy OrthopaedicsActive, not recruitingOsteoarthritis | Post Traumatic ArthritisUnited Kingdom, Netherlands, Canada, Germany
-
Cynosure, Inc.CompletedBenign Pigmented Lesions | Wrinkle | Benign Vascular LesionsUnited States